Patient-reported Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Harboring DNA Damage Response Alterations Treated with Talazoparib: Results from TALAPRO-1. (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.eururo.2022.05.030
PubMed Identifier: 35750582
Publication URI: http://europepmc.org/abstract/MED/35750582
Type: Journal Article/Review
Volume: 83
Parent Publication: European urology
Issue: 4
ISSN: 0302-2838